Sign Up to like & get
recommendations!
0
Published in 2025 at "Current pharmaceutical design"
DOI: 10.2174/0113816128379816250712091207
Abstract: BACKGROUND The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted the urgent need for effective antiviral and anti-inflammatory therapies. Spiropyridine derivatives containing a chalcone moiety have shown potential in targeting key enzymes involved in viral replication…
read more here.
Keywords:
sars cov;
cpla2;
ic50 values;
spiropyridine derivatives ... See more keywords